Findx
EnglishEnglish
Dansk Dansk

Vylor, Inc. stock analysis VYLR.US

Corteva, Inc. is an agricultural sciences company specializing in seed genetics and crop protection. In its seed business, Corteva develops hybrid and trait-enhanced seeds under brands such as Pioneer®, Brevant®, and others. Key seed trait technologies include Vorceed™ Enlist® corn, which combines multiple modes of action against corn rootworm and weeds; PowerCore® Enlist® corn, which combines insect protection with Enlist herbicide-tolerance; Optimum® GLY canola offering advanced glyphosate-tolerant traits; and Pioneer Z-Series soybeans, which are bred for improved yield and agronomic performance.

On the crop protection side, Corteva produces herbicides, fungicides, insecticides, nematicides, and biologicals. Notable products include Forcivo™ fungicide (for control of multiple foliar diseases in crops like corn and soybeans), Aproach® Prima fungicide (dual modes of action for disease control such as tar spot), Viatude™ fungicide (white mold protection in soybeans), and seed treatments like Lumivia® CPL for insect protection in cereals, pulses, and lentils. Active ingredients developed by Corteva include Arylex™ (postemergence broadleaf weed control in cereals), Inatreq™ (cereal disease protection), Zorvec™ (downy mildew and late blight control in specialty crops), and Isoclast™ insecticide (sap-feeding pest control).

Corteva operates globally, offering its seed and crop protection products in many agricultural regions. Seeds are sold through multiple brands with distribution via retail networks and independent seed companies across North America, Latin America, Europe, Asia Pacific, and other regions. Crop protection offerings serve row crops such as corn, soybeans, cereals, rice, and potatoes, as well as specialty crops including vegetables, tree nuts, and citrus. Its R&D pipeline spans development of new trait stacks (for example combining herbicide tolerance and insect resistance), advanced active ingredient discovery, and gene-editing technologies aimed at disease resistance.

Basic Materials · Agriculture · Farm Supplies · United States
Quality
Quality
Momentum
Momentum
Strength
Strength
Entry
Entry: Not yet
A classic falling-knife setup. Price is below SMA 20 and the moving averages are declining. Early bounces inside downtrends often fade. Wait for price to reclaim SMA 20 and for the slopes to stop falling before considering an entry.
Trend
Trend: Trend broken
Trend broken. Two or more consecutive closes below SMA 50 signal that the medium-term trend has flipped. Exiting here is the rule rather than the exception.
‹
›

Click to see warnings

Neg. values

Log in
‹
›
Years
Lower P/E (Bear)
Sign in to view
Fair Value
Sign in to view
Upper P/E (Bull)
Sign in to view
Analysts
Sign in to view
Price: Financials: Q2 FY2026 / FY2025TTM presentEstimates: UnavailableScored as: Standard companyEvidence: LimitedDetails

Freshness

  • Price through:
  • Latest annual period: FY2025 (); filed
  • Latest interim period: Q2 FY2026 (); filed
  • TTM period: ; used by: Quality, Strength
  • No future Diluted EPS estimate is available.
  • Normalized EPS: , 1 analyst
  • Target price: , 4 analysts

Scoring profile

Effective scoring profile: Standard company

Report a suspected classification error

Score evidence

Quality: Score calculated; High confidence; TTM used
Business Momentum: Score calculated; Good confidence; TTM not used
Strength: Score calculated; Limited confidence; TTM used
  • Limited confidence for Strength by model design: diluted EPS stood in for normalized EPS.

Sources and adjustments

Remaining score inputs are provider supplied.

  • Debt to operating cash flow: derived by Findx
  • Net debt to EBITDA: derived by Findx

Key stock metrics

Blended P/E  :
N/A
Blended EPS  :
USD N/A
Blended EPS Yield  :
N/A
Dividend Yield :
(Trailing 12 months)
1.07%
Buyback Yield :
(Trailing 12 months)
2.23%
Market Cap:USD 44,875.60 M
EUR 39,871.97 M

Valuation basis

Analyst price target
How this valuation works
Yearly EPS growth  :
( years incl. estimate)
N/A

P/E Values

Upper P/E:
Fair Value P/E  :
Lower P/E:
Market P/E  :
Sign in to view

EPS Estimates

:
N/A
:
N/A
:
N/A

About Vylor, Inc.

Description and highlights from the latest financial report

DESCRIPTION

Corteva, Inc. is an agricultural sciences company specializing in seed genetics and crop protection. In its seed business, Corteva develops hybrid and trait-enhanced seeds under brands such as Pioneer®, Brevant®, and others. Key seed trait technologies include Vorceed™ Enlist® corn, which combines multiple modes of action against corn rootworm and weeds; PowerCore® Enlist® corn, which combines insect protection with Enlist herbicide-tolerance; Optimum® GLY canola offering advanced glyphosate-tolerant traits; and Pioneer Z-Series soybeans, which are bred for improved yield and agronomic performance.

On the crop protection side, Corteva produces herbicides, fungicides, insecticides, nematicides, and biologicals. Notable products include Forcivo™ fungicide (for control of multiple foliar diseases in crops like corn and soybeans), Aproach® Prima fungicide (dual modes of action for disease control such as tar spot), Viatude™ fungicide (white mold protection in soybeans), and seed treatments like Lumivia® CPL for insect protection in cereals, pulses, and lentils. Active ingredients developed by Corteva include Arylex™ (postemergence broadleaf weed control in cereals), Inatreq™ (cereal disease protection), Zorvec™ (downy mildew and late blight control in specialty crops), and Isoclast™ insecticide (sap-feeding pest control).

Corteva operates globally, offering its seed and crop protection products in many agricultural regions. Seeds are sold through multiple brands with distribution via retail networks and independent seed companies across North America, Latin America, Europe, Asia Pacific, and other regions. Crop protection offerings serve row crops such as corn, soybeans, cereals, rice, and potatoes, as well as specialty crops including vegetables, tree nuts, and citrus. Its R&D pipeline spans development of new trait stacks (for example combining herbicide tolerance and insect resistance), advanced active ingredient discovery, and gene-editing technologies aimed at disease resistance.

ADDITIONAL INFO

LATEST FINANCIAL RESULTS

FILING_DATE: 2026-07-30

FILING_TYPE: Q2 2026 8-K (Results)

PERIOD_COVERED: 2026-04-01 - 2026-06-30

KEY FINANCIAL HIGHLIGHTS

  • •Q2 2026 net sales $6.379B (-1% YoY); organic sales -2% with price/mix +1% and volume -3%. Regional net sales: North America -2%, EMEA -2%, LatAm +1%, APAC +3%.
  • •Q2 2026 GAAP income from continuing operations $1.22B (-12% YoY) and GAAP EPS $1.81 (-10%); Operating EBITDA $2.26B (+4% YoY) with >190 bps margin expansion; Operating EPS $2.30 (+5% YoY).
  • •1H 2026 cash used in operating activities was $3.357B (vs. $1.162B used in 1H 2025); cash and equivalents ended at $2.619B.

WARNING SIGNS & CONCERNS

  • •Competitive pricing pressure in Latin America weighed on Crop Protection: Q2 price -4% (segment net sales $1.847B vs. $1.919B in Q2 2025) and 1H price -3%, indicating ongoing margin headwinds in that region.
  • •1H 2026 operating cash outflow reflected sizable pension/OPEB contributions of $1.140B and working-capital outflows (e.g., deferred revenue -$3.187B), which materially pressured free cash generation in the first half.

MAJOR DEVELOPMENTS

  • •FY 2026 outlook raised: Operating EBITDA now $4.1 - $4.3B (≈+9% at midpoint) and Operating EPS $3.60 - $3.80 (≈+11% at midpoint).
  • •Separation update: Company remains on track to separate into two public companies on October 1, 2026; Investor Day events planned for September 15, 2026, and Form 10 process underway.

It is very important that you understand this

Fair Value is an estimate, and you choose the basis it is built on. Do not invest based on our default without understanding how we calculate it.